CRL – IMPORTANT DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Charles River Laboratories International, Inc. with Losses of $100,000 to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Charles River Laboratories International, Inc. (“Charles River” or “the Company”) (NYSE: CRL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

https://www.accesswire.com/users/newswire/images/718659/1schall-logo.jpg

Investors who purchased the Company’s securities between May 5, 2020 and February 21, 2023, inclusive (the “Class Period”), are encouraged to contact the firm before July 18, 2023.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Charles River illegally imported non-human primates for research purposes. The Company was at risk of investigations by the DOJ among other agencies. The Company was forced to suspend importation of primates from Cambodia. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Charles River, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com

SOURCE: The Schall Law Firm

FRG – ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Franchise Group, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2023 /The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Franchise Group, Inc. (“Franchise Group” or “the Company”) (NASDAQ: FRG) for potential breaches of fiduciary duty on the part of its directors and management in connection with the Company’s agreement to be acquired by a consortium led by CEO Brian Kahn (“the Consortium”).

https://www.accesswire.com/users/newswire/images/718659/1schall-logo.jpg

The investigation focuses on determining if the Franchise Group board breached its fiduciary duties to shareholders by failing to conduct a fair process prior to the agreement, and whether the Consortium is underpaying for the Company.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com

SOURCE: The Schall Law Firm

ETWO – ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against E2open Parent Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of E2open Parent Holdings, Inc. (“E2open” or “the Company”) (NYSE: ETWO) for violations of the securities laws.

https://www.accesswire.com/users/newswire/images/718659/1schall-logo.jpg

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com

SOURCE: The Schall Law Firm

KDNY – ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Chinook Therapeutics, Inc. (“Chinook” or “the Company”) (NASDAQ: KDNY) for violations of the securities laws.

https://www.accesswire.com/users/newswire/images/718659/1schall-logo.jpg

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Chinook is the subject of a report issued by Muddy Waters Research on May 16, 2023. According to the report, the Company’s lead product candidate “has been shown to be harmful to patients’ cardiovascular health”, and that “AbbVie and Chinook seem to have systemically manipulated research findings and presentation on atrasentan to obscure these trial results.” Based on this news, shares of Chinook fell by almost 4.5% on the same day.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com

SOURCE: The Schall Law Firm

MVST – IMPORTANT INVESTIGATION ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Microvast Holdings, Inc. and Encourages Investors with Losses to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Microvast Holdings, Inc. (“Microvast” or “the Company”) (NASDAQ: MVST) for violations of the securities laws.

https://www.accesswire.com/users/newswire/images/718659/1schall-logo.jpg

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Microvast is the subject of a Reuters report published on May 22, 2023. According to the report, the Department of Energy canceled a $200 million grant to the Company that was intended to build a plant in Tennessee to produce lithium batteries. According to the report, the Company’s alleged ties to the Chinese Communist Party are the reason the grant was canceled. Based on this news, shares of Microvast fell by more than 36%.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at [email protected]

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.
310-301-3335
[email protected]
www.schallfirm.com

SOURCE: The Schall Law Firm